Heartburn Drug Launched in India


The UK based company Reckitt Benckiser, has launched the heartburn medication, Gaviscon, in the Indian market. The medicine which is widely used in the UK and Europe, reportedly gives relief from symptoms of heartburn and acidity in just 3 minutes and its effect lasts up to 4 hours. Heartburn is caused by a reflux of acid contents (acid, bile and pepsin) into the food pipe which causes a painful burning sensation near the chest area. Company sources claim that Gaviscon has a non-systemic mode of action and it does not interfere with the body’s digestive process while effectively relieving the symptoms of heartburn.
Following the launch of the drug, the company conducted a scientific conference in Chennai on the ‘Management of Gastro-Esophageal Reflux Disease (GERD) in the 21st century.’ The conference was supported by Dr Robert Heading, President of the Association of Gastrointestinal Physiologists and Prof. Pali Hungin, Founder member of the UK and the European Society for Primary Care Gastroenterology and engaged over 200 international delegates.

For more information about Prime Endoscopy Bristol, click here.